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Abstract
Background: Recruitment to randomised controlled trials (RCTs) can be challenging, with most trials not reaching
recruitment targets. Randomised feasibility studies can be set up prior to a main trial to identify and overcome
recruitment obstacles. This paper reports on an intervention—the QuinteT Recruitment Intervention (QRI)—to
optimise recruitment within a randomised feasibility study of surgical treatments for patients with Dupuytren’s
contracture (the HAND-1 study).
Methods: The QRI was introduced in 2-phases: phase 1 sought to understand the recruitment challenges by
interviewing trial staff, scrutinising screening logs and analysing audio-recorded patient consultations; in phase 2 a
tailored plan of action consisting of recruiter feedback and training was delivered to address the identified
challenges.
Results: Two key recruitment obstacles emerged: (1) issues with the recruitment pathway, in particular methods to
identify potentially eligible patients and (2) equipoise of recruiters and patients. These were addressed by liaising
with centres to share good practice and refine their pathway and by providing bespoke feedback and training on
consent discussions to individual recruiters and centres whilst recruitment was ongoing. The HAND-1 study
subsequently achieved its recruitment target.
Conclusions: Transferable lessons learnt from the QRI in the feasibility study will be implemented in the definitive
RCT, enabling a “head start” in the tackling of wider issues around screening methods and consent discussions in
the set up/early recruitment study phases, with ongoing QRI addressing specific issues with new centres and
recruiters. Findings from this study are likely to be relevant to other surgical and similar trials that are anticipated to
encounter issues around patient and recruiter equipoise of treatments and variation in recruitment pathways across
centres. The study also highlights the value of feasibility studies in fine-tuning design and conduct issues for
definitive RCTs. Embedding a QRI in an RCT, at feasibility or main stage, offers an opportunity for a detailed and
nuanced understanding of key recruitment challenges and the chance to address them in “real-time” as recruitment
proceeds.
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Key messages regarding feasibility
 What uncertainties about feasibility existed prior to
this study?
Recruitment to a randomised trial to assess the effect-
iveness of treatment for Dupuytren’s contracture was an-
ticipated to be challenging due to differences between
procedures in the speed of recovery and risk of disease
recurrence, and the likelihood of recruiting clinicians
and patients having preferences towards a particular
procedure.
 What are the key feasibility findings from this study?
Embedding a QuinteT Recruitment Intervention (QRI)
within the HAND-1 study exposed key recruitment ob-
stacles with regards to methods for identifying poten-
tially eligible trial participants and individual recruiter
and patient equipoise. Strategies, including sharing of
findings giving examples of good practice and training
on consent discussion, were implemented at individual,
centre and whole study level to address the identified
challenges and optimise recruitment.
 What are the implications of the feasibility findings
on the design of the main study?
These findings have implications for the design and
conduct of the main study including the need for early
discussions with centres regarding effective (and less ef-
fective) screening methods, and upfront and continued
training on consent discussions, in particular conveying
equipoise and engaging with patients’ treatment
preferences.
Background
Randomised controlled trials (RCTs) are widely acknowl-
edged as the gold standard study design for establishing
the effectiveness of interventions [1]. However, recruiting
to RCTs is challenging, and only half reach recruitment
targets [2], with studies facing early closure or an extended
recruitment period [3]. Randomised feasibility studies can
help to identify problems with recruitment in advance of a
definitive RCT, including barriers to participation and the
identification of clinician training needs [4]. This paper re-
ports on an intervention embedded into a feasibility hand
surgery RCT that aimed to identify and overcome barriers
to recruitment and informed consent prior to a main trial.
The HAND-1 study was a two-arm randomised study
developed to assess the feasibility and to inform the de-
sign of a large multicentre RCT to compare the clinical
and cost-effectiveness of treatments for Dupuytren’s
contracture. Dupuytren’s contracture is a thickening of the
connective tissue in the palm of the hand that eventually re-
sults in one or more affected fingers being permanently bent
in towards the palm—adversely affecting patients’ hand func-
tion and ability to carry out everyday tasks [5]. Currently,
there is a lack of high-quality evidence comparing two surgi-
cal treatments for primary Dupuytren’s contracture: limited
fasciectomy (LF) and needle fasciotomy (NF) [6]. Both NF
and LF are currently performed within the National Health
Service (NHS) in England. LF is most commonly under-
taken, but NF is less costly for health services, at least in the
short term. Dupuytren’s contracture can come back after
both NF and LF, such that further surgery may be needed,
though recurrence is more common after NF [7].
Recruitment to the HAND-1 study was anticipated to
be challenging due to (a) differences between the proce-
dures in the speed of recovery and risks of recurrence
and need for revision surgery [7, 8] and (b) the likeli-
hood of recruiting clinicians and patients not being in
equipoise and having preferences towards one or the
other procedure. Clinical equipoise is the state of uncer-
tainty which arises when no one procedure is considered
to be more or less beneficial for treating a patient group
than its comparators [9]. Conveying equipoise to pa-
tients during trial recruitment can be challenging and re-
quires recruitment staff to present treatments in a
balanced way and avoid unwittingly conveying any per-
sonal beliefs to patients about the superiority of any pro-
cedure, given the lack of robust evidence [10]. Ensuring
that patients are well-informed about the treatment op-
tions is equally crucial and a basic requirement of good
clinical practice. To enable this, recruiters need to be
comfortable exploring the basis of patients’ treatment
preferences to expose and address any concerns and
misconceptions and ensure that trial participation deci-
sions are based on full and accurate information [11].
Given the anticipated difficulties, a QuinteT Recruitment
Intervention (QRI) was embedded into HAND-1 to opti-
mise recruitment and informed consent. The QRI aims to
rapidly identify recruitment difficulties and offers tailored
solutions whilst recruitment continues [12]. Having evolved
over two decades, the intervention has been implemented
in over 30 RCTs, leading to insights about recruitment is-
sues across a variety of trial contexts and the development
of evidence-based strategies to address them [13–16].
This paper reports on the identification of barriers to
recruitment and informed consent through the QRI, and
the strategies designed and delivered to overcome them,
enabling the study to recruit to target. The main results
of HAND-1 feasibility study are reported separately [17].
Methods
The HAND-1 feasibility RCT
Patients who met the inclusion criteria [6] were re-
cruited from three secondary care centres in England.
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Recruitment was undertaken by hand surgeons (lead re-
cruiters) and research nurses (or supporting recruitment
staff) between November 2015 and September 2016.
Lower and upper recruitment targets of 50–85 patients
were set before the study commenced. Patients who
agreed to participate were randomised on a 1:1 ratio to
receive either NF or LF. A range of patient reported, and
clinical outcome measures were collected to test their
appropriateness for the main trial [6].
The embedded QuinteT Recruitment Intervention
The QRI has two phases. Phase 1 sought to identify and
understand recruitment challenges using multiple
methods, including qualitative interviews with trial staff,
scrutiny of screening logs and analysis of audio-recorded
consultations in which the trial was discussed and pa-
tients invited to participate. Phase 2 involved designing
and implementing a tailored plan of action to address
the challenges identified in phase 1. This entailed site
and individual feedback, training and support. Recruit-
ment rates were plotted over time to examine trends in
recruitment and their association with the timings of
QRI interventions. Data collection for phase 1 of the
QRI took place soon after recruitment commenced (No-
vember 2015) until May 2016, to allow time for centres
to receive training and feedback and for this to poten-
tially impact recruitment.
Phase 1
Interviews with HAND-1 trial staff
Semi-structured interviews with key trial management
group (TMG) members and HAND-1 recruitment staff
were undertaken by SH. Staff were invited for telephone
interview via e-mail; those who did not respond were
sent a reminder one week later. A flexible interview
topic guide (available as supplementary material) was de-
veloped based on those used in previous QRIs [12] with
questions focusing on perceived issues with recruitment
and how trial processes and consultations were being
conducted.
Interviews were transcribed verbatim and checked
against audio-recordings for accuracy. Interview
transcripts were imported into NVivo10 and coded line-
by-line for emerging themes. Data were assigned repre-
sentative labels and analysed using techniques of con-
stant comparison, which requires new data to be
continually compared with existing data to enhance un-
derstanding and explore relationships between themes
[18]. A coding structure was developed and refined to
take account of new and evolving themes as analysis
progressed. Descriptive accounts were generated to com-
pare interview responses under each theme. Analysis
was primarily undertaken by SH, with 10% of transcripts
double-coded by DE to enhance reliability [19].
Analysis of screening log data
All centres were encouraged to keep detailed screening
logs of their recruitment activities, including numbers of
patients screened, eligible, approached and recruited
(SEAR framework) [20], and reasons for non-
participation. Centres received training on completing
the logs and were sent reminders every two weeks to
complete them in full and upload them to the trial data-
base. Data were collated by the Nottingham Clinical Tri-
als Unit (NCTU) and screening logs were analysed using
simple counts to display numbers and proportions of pa-
tients at each stage of the eligibility and recruitment
process.
Recorded consultations offering participation
Patients were posted information about audio-recording
their discussion with the surgeon before their NHS clinic
appointment where recruitment occurred. At clinic, re-
cruitment staff were encouraged to routinely approach all
patients for permission to audio-record. Patients who
agreed provided written informed consent. Recordings
were captured on encrypted audio-recorders, transcribed
verbatim and analysed using methods of constant com-
parison (as described above). Analysis focused on inter-
action between recruiters and patients to compare
recruiter explanations of the study and patient responses.
Techniques inspired by conversation analysis [21] were
used to study in-depth aspects of communication that ap-
peared to hinder recruitment. A sub-sample of appoint-
ment transcripts was double-coded by DE and NM.
Recruiter training in phase 1
Training recruiters is typically undertaken in phase 2 of
the QRI, but opportunities arose to offer early training
based on findings from previous QRIs [14]. In the second
month of recruitment (13 January 2016), a training session
was embedded within a collaborator’s meeting and a gen-
eral recruitment tips document was circulated to all staff.
The meeting was attended by surgeon C and research
nurses and other supporting staff from all centres.
Phase 2
In phase 2, findings from phase 1 were presented in a re-
port to the chief investigator (CI) and TMG (28 Febru-
ary 2016). This detailed recruitment obstacles within
and across centres, and presented anonymised trial staff
interview, recruitment consultation audio-recordings
and screening log data as evidence. Findings were dis-
cussed, and a tailored plan of action developed for each
centre, focusing on the delivery of targeted recruitment
feedback by the QRI team.
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Results
A total of 267 patients were assessed for eligibility be-
tween November 2015 and September 2016, of which
153 (57%) were eligible. Seventy-one (46%) of these were
randomised to receive NF or LF, which was within the
pre-set recruitment target range of 50–85 participants
demonstrating that a main trial would be feasible.
Interviews with HAND-1 trial staff
Eight HAND-1 staff were approached for interview, of
which seven agreed. Interviews took place between De-
cember 2015 and February 2016 with one TMG mem-
ber, and a recruiting surgeon (n = 3) and research nurse
(n = 3) from each centre (Table 1). The lead recruiter in
centre 3 was not available for interview, but another re-
cruiter in the centre was interviewed (surgeon A). Inter-
views lasted 30 min on average (range 15–50min).
Recorded consultations offering participation
Of 267 patients assessed for eligibility for the trial across
the 3 centres, 115 were approached for audio-recording
between December 2015 and September 2016, and 86
(74%) agreed. For this study, analysis focused on the
practices of two of the three lead recruiting surgeons
(surgeon B and C) from two of the centres, as they were
the only recruiters with audio-recordings pre- and post-
feedback. However, insights through interviews with a
recruiting surgeon from the third centre were included
in the phase 1 analysis. Seventy-two patients were
approached for audio-recording by surgeon B and C,
and 65 agreed (90%). Of these 65 recordings, 37 were
made in phase 1 and 28 in phase 2, after all training had
been delivered.
Phase 1 results: key recruitment obstacles
Organisational issues: variation of patient pathways
Recruitment figures from screening logs in the first three
months of recruitment indicated differences in recruit-
ment activity across centres. Centre 2 had screened and
recruited fewer patients than centre 1 (7 screened com-
pared to 19 and 2 recruited compared to 5), even though
centre 2 had an expected higher volume of eligible
patients. Descriptions of patient recruitment pathways
during staff interviews highlighted differences in how pa-
tients were screened (Fig. 1), which was likely to have
explained the observed differences in numbers of poten-
tially eligible participants identified. Centre 1 screened
GP referral letters to ensure all patients were guided to a
“recruitment clinic” in advance, and centre 3 screened
patient notes on the day of clinic. Eligible patients in
both centres were given a study patient information
sheet (PIS) to look at in clinic, and the opportunity to
discuss the study with members of the recruitment team.
At centre 2, however, centre staff opted to send a study
invitation letter and leaflet by post, asking patients to
call in advance of their appointment to “opt-in” to a re-
search clinic to discuss participation in HAND-1. Op-
portunities for these patients to discuss the study with
staff before deciding whether or not to opt-in to the re-
search clinic were therefore limited.
Presenting the RCT to patients: patient preferences and
surgeon equipoise
Recruitment figures around the time of staff interviews (Feb-
ruary 2016) demonstrated that 81% of eligible patients who
declined participation were doing so because they favoured
either NF or LF. These figures aligned with opinions of re-
cruitment staff, particularly recruiting surgeons, who sug-
gested that patients would have strong views on which
treatment, or aspects of treatment, would be most appropri-
ate (Table 2). If patients voiced a preferred treatment, they
suggested they would respect this and offer them their treat-
ment of choice (Table 3). This played out in practice, with
surgeons B and C tending to accept expressed treatment
preferences early on in discussions, often without exploring
what patients understood by the treatments and therefore
how informed they were about them (Table 4). In example
consultation 2 (Table 4), surgeon B missed opportunities to
address a patient’s concern about scarring with LF, without
also balancing this with information about the decreased
likelihood of Dupuytren’s contracture reoccurring after LF
compared to NF. Both patients in these examples opted to
receive their initial treatment preference.
Recruiters were also observed presenting imbalanced
information on treatment options, possibly unwit-
tingly, in the language they used, for example, in de-
scribing LF as “a major event” but NF as “something
simpler” (surgeon C) or using less positive language
to describe one operation “there’s LF…some people
would call it bog-standard…. I don’t know it’s the
best” (surgeon B). In the case of surgeon B, this im-
balanced presentation appeared to be influenced by a
personal preference for NF, with instances of patients
being guided, inadvertently or otherwise, towards
choosing NF. In these cases, the patient declined trial
participation requesting NF instead (Table 5).
Table 1 HAND-1 interview participants
Participant ID Centre Role in HAND-1 study
Surgeon A Centre 3 Recruiter
Surgeon B Centre 2 Lead recruiter at centre 2
Surgeon C Centre 1 Lead recruiter at centre 1/TMG member
Research nurse A Centre 3 Research nurse
Research nurse B Centre 2 Research nurse
Research nurse C Centre 1 Research nurse/assistant
TMG member A N/A TMG member
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Phase 2: strategies implemented to address identified
recruitment difficulties
The plan of action consisted of written reports to the
TMG, written individual feedback to recruiters on re-
cruitment consultations and face-to-face, centre-specific
training sessions focusing on key recruitment obstacles
identified in phase 1. These were delivered between Feb-
ruary and early August 2016 (see Table 6).
The written report to the TMG (February 2016) de-
tailed obstacles to recruitment across the centres, based
on analysis of screening logs, staff interviews (n = 8) and
audio-recordings available at the time (n = 11). The re-
port was accompanied by a list of potential actions to
address issues highlighted.
Face-to-face visits to centres 1 and 2 took place in
May 2016. Feedback sessions used anonymised data
from HAND-1 consultations to demonstrate how
Fig. 1 Patient recruitment pathways for HAND-1 across recruiting centres. *Patient RCT eligibility confirmed by recruiting surgeon in clinic
Table 2 Extracts from interviews: recruiters’ perception of
patient equipoise
Example 1:
Surgeon C (centre 1, interview): “[Patients] will have strong
preferences for one or the other operation…one has a quicker recovery
but is more likely not to straighten the finger fully and have to be
repeated, some people will say, ‘…As long as it can be repeated, I’m
happy.’ Others say, ‘…I want a once-and-for-all, if possible, treatment,’
and go for the bigger one.”
Example 2:
Surgeon B (centre 2, interview): “I get a lot of musicians…rock
climbers…people like electricians, self-employed who are having trouble
with their job, but can’t take six weeks off work with LF…So it may be
that actually, equipoise is not possible because patient choice will deter-
mine LF so critically.”
Husbands et al. Pilot and Feasibility Studies           (2020) 6:173 Page 5 of 11
different approaches to presenting study information ap-
peared to impact patients’ decisions, for example, how
presenting information in favour of one treatment over
another would (often unwittingly) sway patients towards
the weighted treatment. Guidance was offered on how
lead recruiters could optimally manage aspects of re-
cruitment discussions, such as techniques to explore the
rationale for treatment preferences, to allow patient con-
cerns or misconceptions to be unearthed and explored.
After feedback sessions, an e-mail was sent to centres
with a list of agreed actions, which included adjustments
to the recruitment pathway in centre 2 and changes to
aspects of recruiters’ approaches to explaining the study
in centres 1 and 2 (Table 6). Changes to centre 2’s re-
cruitment pathway involved the appointment of staff to
screen clinic letters and an additional recruiting surgeon
(surgeon D), allowing all patients to be screened and
approached for HAND-1 participation during their clinic
visit. Surgeon B and C also received confidential and tai-
lored written feedback on their recruitment consulta-
tions, for example, highlighting how their choice of
words and proportion of time spent describing treat-
ments could unwittingly steer patients towards a
particular procedure, with tips and guidance on how to
overcome to present better balanced information.
Centre-specific or individual recruiter feedback could
not be delivered to centre 3. Instead, a tailored written
tips document on addressing patient preferences was cir-
culated, as this centre’s screening logs demonstrated pa-
tients were declining study participation because of a
preference for one of LF or NF.
Observed changes to recruitment and informed consent
HAND-1 successfully reached its recruitment target, with in-
creases in recruitment occurring soon after the delivery of
QRI interventions. For example, conversion rates (patients
approached/randomised) increased in centre 1 in the months
soon after surgeon C had received feedback on recruitment
obstacles (Feb 2016, see Table 7 and Fig. 2). Figures from
centre 2 suggested increases to conversion rates in the
months after their training visit (May 2016, see Table 7 and
Fig. 3). This increase appeared to be related to a rise in the
number of patients screened, which occurred after suggested
changes to the recruitment pathway were implemented. The
new recruiting surgeon at centre 2 (surgeon D) also received
feedback on his recruitment appointments just prior to this
observed increase (August 2016, see Table 7 and Fig. 3). In
centre 3, we were unable to provide feedback from consult-
ation recordings, but there was a marked increase in recruit-
ment numbers and conversion rates (Table 7) following the
delivery of a tailored recruitment tips document (Table 6)
which focused on likely key issues derived from other cen-
tres, screening logs and an interview with a centre recruiter
(surgeon A). Recruitment figures from all centres, however,
showed that increases after interventions appeared to tail off
after several months, particularly towards the end of
recruitment.
A comparison of audio-recordings pre- and post-
feedback suggested that recruiters had changed the way
they explained the study, in line with guidance from the
QRI team. There were instances of surgeon C exploring
Table 4 Excerpts from recruitment consultations: recruiter
responses to patient treatment preferences
Example consultation 1 (surgeon C, centre 1):
Patient 16: “I think I’d like to have, would prefer to have, limited
fasciectomy.”
Surgeon C: “No, that’s absolutely fine”
Example consultation 2 (surgeon B, centre 2):
Patient 6: [referring to LF surgery] “When I look at all this scarring and
everything, I think it looks really ugly…. And the fact is that it
[Dupuytren’s contracture] will come back anyway.”
Surgeon B: “Yes.”
Patient 6: “I think probably I would prefer the needle….”
Surgeon B: “Okay”
Table 5 Excerpt from recruitment consultation regarding
surgeon equipoise
Patient 17: “When I came in today, my thought was, the recovery time
was a minus [of LF]. Scars or…lumps, doesn’t bother me in the slightest.
So, I suppose I had in my mind the needle option. If you were saying to
me a better recovery will be surgery, I’m not anti-surgery…. I suppose I
want it done as quickly as possible. I would certainly be guided by
yourself.”
Surgeon B: “Okay. This [centre] has a reputation for doing NF…and
people come to us for that reason…. they say, ‘Getting back to work
rapidly is my highest priority. I’m willing to put up with it coming back’.”
Patient 17’s wife: “Ah, that was a question I was going to ask you. If
[Patient 17] had it done by needle now and it did not, in time he could
then have it cut and done…. Because that would give you options at
work now, wouldn’t it?”
Surgeon B: “Yes.”
Patient 17: “Mmm-hmm”
[Patient 17 opts for Needle Fasciotomy]
Table 3 Extracts from interviews: recruiters’ intended response
to voiced preferences
Example 1:
Surgeon A (centre 3, interview): “So, obviously if they have already
decided then fine, they’ll [get it]. We respect their decision…”
Example 2:
Interviewer: “What do you plan to do if a patient does decline
[because of a preference]?”
Surgeon B (centre 2, interview): “Offer them the treatment of their
choice.”
Example 3:
Interviewer: “Why do you think patients might decline to take part in
the trial?”
Surgeon C (centre 1, interview): “Because of a preference…There are
many reasons [why], and I think you’ve just got to accept some people
will have views as to what suits them better”
Interviewer: “What will you do if a patient does decide to decline to
take part?”
Surgeon C (centre 1, interview): “That’s fine. They will be asked which
treatment they want to have…Then on the NHS they’ll have the
treatment they wish…”
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Table 6 HAND-1 QRI interventions




Recruiter training presentation given at
collaborators’ meeting











Full QRI report sent to CI and TMG members
(including suggested actions)
Surgeon C, centre 1 (as a





Site-specific feedback visit/training to centre 1 Surgeon C, research nurse C
and other staff involved with
recruitment in centre 1
Carefully consider recruitment practices—specifically
to explore and address treatment preferences rather




Site-specific feedback visit/training to centre 2 Surgeon B, research nurse B
and other staff involved with
recruitment in centre 2
Streamline patient recruitment pathway. Carefully
consider recruitment practices—specifically to provide
more balanced overview of procedures and explore





Individual and tailored written feedback sent to
recruiting surgeons
Surgeon B, surgeon C and 1
additional recruiter (surgeon





Tailored tips document (based on issues
identified from screening log data e.g.
addressing patient treatment preferences)






Individual and tailored written feedback Surgeon D, centre 2 N/A
Table 7 HAND-1 recruitment figures for all centres
Centre/month No. screened No. eligible/approached No. randomised Conversion rate (approached/randomised)
Centre 1
Dec 2015/Jan 2016 12 7 1 14%
Feb–Apr 2016 27 17 14 82%
May–July 2016 35 23 13 56%
Aug/Sept 2016 26 16 8 50%
Centre 2
Dec 2015/Jan 2016 7 4 2 50%
Feb–Apr 2016 21 11 1 9%
May–July 2016 65 27 5 18%
Aug/Sept 2016 26 9 4 44%
Centre 3
Dec 2015/Jan 2016 8 6 3 50%
Feb–Apr 2016 20 15 7 46%
May–July 2016 13 8 6 75%
Aug–Sept 2016 14 11 6 54%
Key dates of QRI feedback:
Centre 1:
• 28 February 2016—Full QRI report received by lead recruiter (surgeon C) in centre 1
• 10 May 2016—Site-specific feedback/training visit to centre 1
• 18 May 2016—Individual and tailored written feedback to recruiters in centre 1
Centre 2:
• 11 May 2016—Site-specific feedback training visit to centre 2
• 18 May 2016—Individual and tailored written feedback to lead recruiter (surgeon B) in centre 2
• 01 August 2016—Individual and tailored written feedback to surgeon D in centre 2
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and balancing patient treatment preferences as advised,
specifically using the advantages/disadvantages of a pa-
tient’s most/least preferred option to gently challenge
their views and emphasise the position of clinical equi-
poise (Table 8). Similarly, there were examples of sur-
geon B providing more balanced information on
procedures, including comparatively more positive de-
scriptions of LF (Table 8). Such changes though were in-
consistent within and across their appointments, but
there were signs of behaviour change during the consult-
ation in the limited post-training timeframe.
Discussion
This paper has reported on the integration of an interven-
tion (the QRI) to optimise recruitment and informed con-
sent to a feasibility RCT of treatment for Dupuytren’s
contracture (the HAND-1 study). Using multiple methods,
the QRI identified recruitment obstacles and implemented
tailored strategies to address them. There was a steady im-
provement in recruitment, with some of the more pro-
nounced increases occurring soon after delivery of QRI
data feedback and recruiter training. The feasibility study
achieved its recruitment target within the required time-
frame [17], demonstrating that recruitment to a main trial
of NF and LF with integrated QRI is feasible. The QRI
study also demonstrated that it is possible for surgeons to
be trained to recruit into an RCT of two surgical proce-
dures with very different patient experiences, despite some
initial reservations that patient and recruiter equipoise
would hinder participation.
Two key recruitment obstacles emerged from the re-
search. Recruitment pathways, in particular how poten-
tially eligible patients were identified, appeared to be
restricting the pool of eligible patients, especially in
centre 2 where potentially eligible patients were asked to
opt-in to a research clinic if they wanted to hear about
the study. Recruiter equipoise and accepting of patient
preferences at face value also appeared to be impacting
recruitment with instances where recruiters were subtly
steering patients towards one of the treatments, with or
without knowing it, or were not establishing if the pa-
tient fully understood the pros and cons of their pre-
ferred and non-preferred treatment. Interviews with
patients who participated in HAND-1 to explore their
experience of treatment and participation [6] triangu-
lates the finding of an imbalanced delivery of informa-
tion—a few either recalled little information on one of
the treatments compared to the other or conveyed that
one of the treatment options had been portrayed to
them more negatively than the other.
Fig. 2 Recruitment to the HAND-1 Study with QRI interventions—centre 1. QRI interventions: (A) 13 January 2016—recruiter training presentation
attended by surgeon C and recruitment tips document circulated to centre 1. (B) 28 February 2016—full QRI report received by surgeon C in
centre 1. (C) 10 May 2016—site-specific feedback visit/training to centre 1. D 18 May 2016—individual and tailored written feedback sent to
surgeon C
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Recommendations from the QRI included changes to
the recruitment pathway to ensure that centres were
maximising the pool of potentially eligible patients so
that as many patients as possible had the opportunity to
consider trial participation. Recruiting surgeons were
provided with evidence-based training on techniques for
balancing treatment discussions and for gently exploring
patients’ treatment preferences to ensure patients had
full and accurate information [10, 11]. The QRI ap-
peared to lead to positive improvements, as recruitment
rates increased in the periods shortly after interventions
had been delivered, and recruitment practices seemed to
change to promote informed consent. In instances where
recruitment numbers did not increase after intervention
(for example, interventions C and D at centre 1), recruit-
ment numbers remained stable in the months following
the delivery of feedback and training; the interventions
may have positively contributed to this achievement.
These particular interventions were also preceded by
feedback (intervention B) which led to the greatest in-
crease in recruitment numbers at this centre (Fig. 2).
Other studies have highlighted similar recruitment ob-
stacles. Pathway issues were identified in a surgical trial
for bladder cancer, resulting in simplification of the
pathway to reduce the number of professionals that
Fig. 3 Recruitment to the HAND-1 Study with QRI interventions—centre 2. QRI interventions: (A) 13 January 2016—recruitment tips document
circulated to all centres (including centre 2). (B) 11 May 2016—site-specific feedback visit/training to centre 2. (C) 18 May 2016—individual and
tailored written feedback sent to surgeon B. (D) 1 august 2016—individual and tailored written feedback sent to surgeon D
Table 8 Excerpts from recruitment consultations pre and post
intervention
Surgeon C:
Excerpt from consultation pre-feedback (February 2016)
Patient 16: “I think I’d like to have, would prefer to have, surgery.”
Surgeon C: “No, that’s absolutely fine”
Excerpt from consultation post-feedback (March 2016)
Patient 22: “…I would love to do this study but I’m just wondering…
what to do because I’m already going to have six weeks and then if I
have to have another month off, I might not get paid.”
Surgeon C: “No, no, that’s fine. That’s okay. So, which one would you?”
Patient 22: “If I had [needle fasciotomy] it would only be about a
week…?”
Surgeon C: “It would be a shorter period but it’s not so good at getting
it straight. Just sometimes they don’t come straight at all and we have
to go and do the other one anyway. It’s very difficult and that’s why
we’re doing the study because we don’t know which is better”
Patient 22: “Yes, right. I’ll do the study then… it’s not up to me, it’s
down to the study.”
Surgeon B:
Excerpt from consultation pre-feedback (February 2016)
Surgeon B: “Limited fasciectomy has a higher risk of complications but
possibly a longer-term disease-free interval; slightly harder to do repeat-
edly, but you don’t need it doing as often. Needle fasciotomy: faster re-
covery, smaller risk of complications, but you might need it doing more
often”
Excerpt from consultation post-feedback (August 2016)
Patient 68: “I’m not sure how long it’ll be for things like driving?”
Surgeon B: “Needle fasciotomy 5–6 days, but it does come back we
know much faster…Limited fasciectomy, we are probably talking about
3–4 weeks to get back to comfortable, safe driving, but we know that it
is a much longer time to recurrence”
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patients encountered prior to being invited to join the
RCT [22]. Patient treatment preferences were a com-
monly cited obstacle by recruitment staff in other stud-
ies [14, 23]. These studies noted that recruiters believed
patient treatment preferences were responsible for poor
recruitment, and they often did not realise their own in-
fluence on patients’ treatment decisions during discus-
sions and the impact of this on recruitment. Rooshenas
et al. [10] found that equipoise was omitted or under-
mined in almost half of recruitment appointments (48/
105), even though most recruiters considered themselves
to be in equipoise. This stemmed from an imbalanced or
biassed presentation of the treatment options. These
studies, and ours, emphasise the importance of targeted
training to raise awareness and help clinicians to have
more full and open conversations with patients on RCT
participation. Similar targeted training/guidance in other
studies has led to increases in recruitment and informed
consent [11].
This is the first study to explore and address recruit-
ment barriers in-depth in a feasibility study of treatment
for Dupuytren’s contracture. The strength of the QRI
was the identification of common obstacles across cen-
tres and obstacles that were unique to individual re-
cruiters/centres, all of which appeared to affect
recruitment. This allowed focused feedback on the most
salient issues for each centre and individual. All data col-
lection and analysis occurred as recruitment was under-
way, enabling strategies to be devised and implemented
to impact subsequent recruitment.
A limitation of this study is that analysis focuses on
two recruiters in two centres. However, the limited data
gathered from centre 3 largely from screening logs sug-
gested that the recruitment obstacles there were like
those in centres 1 and 2, and those observed in other
QRI studies [14]. As with any before-after observational
research, it is difficult to determine the cause and effect
of the QRI on improvements to recruitment practices.
Other, confounding, factors may have been responsible
for the observations, such as increased recruiter concen-
tration during appointments due to an awareness of be-
ing audio-recorded. However, interventions often
immediately preceded increases in recruitment numbers,
and an analysis of before-after QRI phase 2 actions
within five RCTs (including HAND-1) showed promis-
ing evidence to suggest that the actions designed to ad-
dress issues around approaching patients in the HAND-
1 RCT (centre 2) led to significant improvements in the
number of patients approached per centre per month
[16]. Our analysis has important implications for a full
RCT comparing outcomes after surgical interventions, as
the recruitment obstacles identified here can be mini-
mised in the main trial, for example, by advising on effi-
cient methods of screening for potentially eligible
patients. It has highlighted the fragility of recruitment
processes [24] and the need for continued training for
recruiters throughout RCTs [25], as otherwise the effects
of training/guidance can tail off over time and emerging
new challenges can go undetected. This emphasises the
importance of the continued integration of the QRI in
the full RCT. The study has highlighted lessons that
might be useful to other surgical RCTs, such as the value
of enabling recruitment processes to maximise the iden-
tification of potentially eligible participants and ensuring
that recruiters convey equipoise in their description of
study procedures and explore patient treatment prefer-
ences to confirm fully informed decision-making.
Conclusions
The integration of the QuinteT Recruitment Intervention
into a feasibility study of surgical treatments for Dupuyt-
ren’s contracture (the HAND-1 study) identified obstacles
relating to recruitment and informed consent that were
amenable to change through raising awareness, sharing of
good practice and training throughout the recruitment
period. The HAND-1 study was subsequently successful
in reaching its recruitment target within the required
timeframe. The study has important implications for the
main trial and other surgical or similar trials that are an-
ticipated to encounter issues around patient and recruiter
equipoise of treatments and variation in recruitment path-
ways across centres. Our study has also emphasised the
benefits of including a feasibility study in a trial’s design,
with a clear objective to explore and respond to issues
which may impact negatively on recruitment in prepar-
ation for the main trial [4, 26]. Embedding a QRI in an
RCT, at feasibility or main stage, offers an opportunity for
a detailed and nuanced understanding of key recruitment
challenges and the chance to address them in “real-time”
as recruitment proceeds.
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